[New Stock IPO]Saisheng Pharmaceutical 6600 Margin Records 46.6 billion yuan oversubscription 212.8 times (continuously updated)-Hong Kong Economic Times-Real Time News Channel-Market Finance-IPO

The mainland biopharmaceutical company Saisheng Pharmaceutical (new listing code: 06600) will offer shares from Friday (19th) to next Wednesday (24th).

The mainland biopharmaceutical company Saisheng Pharmaceutical (new listing code: 06600) will offer shares from Friday (19th) to next Wednesday (24th), and will be listed on March 3. Based on data from multiple brokerage firms, by 7 pm, Saisheng Pharmaceutical’s margin trading had recorded 46.625 billion yuan, which has been oversubscribed by 212.8 times. Among them, Phillip lent 12 billion yuan, Yaocai lent 8.2 billion yuan, Futu lent 7.36 billion yuan, and UOB Kayxian lent 4.6 billion yuan.

How many hands are drawn for Saisheng Pharmaceutical, can you secure one hand first?See【Next page】

Saisheng Pharmaceutical’s prospectus details:【Next page】

See the prospectus information of Saisheng Pharmaceutical

    Click on the picture to enlarge

    +3
    +2

Saisheng Pharmaceuticals focuses on treatment areas with significant unmet medical needs, including tumors and severe infections. The company plans to issue 116 million shares and raise up to 2.18 billion yuan. Morgan Stanley, CICC and Credit Suisse are the joint sponsors.

Hong Kong Stock Exchange intends to re-subscribe for Nuohui Health【Next page】

The predecessor of SciClone US, SciClone US, was once listed on NASDAQ (stock code before delisting: SCLN). In 2017, it was privatized by a consortium composed of Telford Capital, Bank of China Group Investment Co., Ltd., CDH Investment, Shangda Capital, and Boying Investment.

【Enhance the cash flow of SMEs. Up to $1,500 reward! Terms and conditions apply]

Track IPO news, you can browse[Initial public offering]Or use【IPO】Gadgets

Read Also:  EBRD expands support for listed companies in the Baltics :: Dienas Bizness

related articles:

[New stock IPO]Sina Weibo rumored to return to Hong Kong as soon as this year, and Alibaba is the second largest shareholder

[New Stock IPO]Dmall plans to go public in the US to raise more than 3.8 billion Tencent has an investment

I want to easily draw new shares and win money!Download now for free[Click here]

Editor: Lai Yiling

Share on facebook
Facebook
Share on pinterest
Pinterest
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Trending